-
WCLH 2025 Concludes Successfully in Copenhagen
Pluslife team met colleagues from programmes, laboratories, and communities to exchange views on TB diagnosis, near-POC molecular testing, and tongue swab–based sampling in real-world settings.
넶39 2025-11-24 -
Pluslife at Stop TB Partnership Board Meeting 39 in Manila
Through direct dialogue with programs, communities and partners, we’re advancing near-POC molecular testing to close TB diagnostic gaps.
넶18 2025-11-10 -
Pluslife Showcased Innovative Molecular Diagnostics at WHX Lagos & WHX Labs Lagos 2025
Pluslife showcased its innovative tuberculosis nucleic acid test platform at WHX Lagos 2025.
넶164 2025-06-05 -
Pluslife at WHA78 Side Event | Contributing to Global Health with China's Diagnostic Innovation
Pluslife participated in the WHA78 side event to share how China’s molecular diagnostic innovation is contributing to improved accessibility and equity in global primary healthcare.
넶271 2025-05-21 -
MEDICA 2024: Innovating Molecular Diagnostics to Drive Decentralized Infectious Disease Testing
Pluslife's solutions empower grassroots testing capabilities and bring a whole new experience to visitors at the event.
넶278 2024-11-14 -
Africa Health 2024: Showcasing Innovation, Revolutionizing and Decentralizing Infectious Disease Testing
Pluslife Shines at Africa Health 2024, Driving Innovation and Decentralization in Infectious Disease Testing.
넶149 2024-10-25
